| Mannose-Binding Lectin 2 Protein |
|---|
| Gene | [MBL2](/entities/mbl2) (Mannose Binding Lectin 2) |
| UniProt ID | [P11226](https://www.uniprot.org/uniprot/P11226) |
| Alternative Names | MBL, Mannose-Binding Protein, Mannan-Binding Lectin |
| Molecular Weight | 26 kDa (monomer), 600 kDa (oligomer) |
| Subcellular Localization | Plasma, secreted |
| Protein Family | Collectin family |
Mannose-Binding Lectin 2 (MBL2) is a key component of the innate immune system and a member of the collectin family of proteins. It functions as a soluble pattern recognition receptor that recognizes carbohydrate patterns on the surface of pathogens, including bacteria, fungi, and viruses. MBL2 plays a critical role in the lectin pathway of complement activation, which is one of the three major pathways of the innate immune system. Beyond its classical immunological functions, emerging research has implicated MBL2 in neurodegeneration through its involvement in neuroinflammation, protein aggregation, and blood-brain barrier integrity.
¶ Structure and Function
MBL2 is a multimeric protein composed of identical polypeptide chains that assemble into higher-order oligomers. The protein structure includes:
- Collagen-like regions: Triple helical domains that mediate trimerization
- C-type lectin domains: Carbohydrate recognition domains (CRDs) that bind to mannose, N-acetylglucosamine, and fucose residues on pathogen surfaces
- Neck regions: Alpha-helical segments that facilitate oligomerization
- N-terminal cysteine-rich regions: Involved in disulfide bond formation
The functional MBL2 protein circulates as large oligomers (typically trimers and hexamers) with molecular weights ranging from 200-600 kDa. This multimeric structure enables high-avidity binding to pathogen surfaces.
MBL2 initiates the lectin pathway of complement activation by:
- Pattern recognition: MBL2 binds to pathogen-associated molecular patterns (PAMPs) on microbial surfaces
- MBL-associated serine protease (MASP) recruitment: MBL2 complexes with MASP-1, MASP-2, and MASP-3
- Complement activation: The MBL-MASP complex cleaves C4 and C2, generating C4b2a (C3 convertase)
- ** downstream complement activation**: This leads to opsonization, inflammation, and lysis of targets
Neuroinflammation is a hallmark of neurodegenerative diseases including Alzheimer's disease (AD) and Parkinson's disease. MBL2 contributes to neuroinflammation through several mechanisms:
- Peripheral immune activation: Circulating MBL2 can activate the complement system, leading to systemic inflammation that propagates to the central nervous system
- Blood-brain barrier (BBB) modulation: MBL2 and complement activation products can compromise BBB integrity, allowing peripheral immune cells to enter the brain
- Microglial activation: Complement components generated by MBL2 activation can bind to microglia receptors, promoting pro-inflammatory cytokine release
In Alzheimer's disease, MBL2 has been studied for its potential protective and pathogenic roles:
- Amyloid-β clearance: Some studies suggest MBL2 may aid in clearing amyloid-beta plaques through complement-mediated phagocytosis
- Synaptic pruning: Excessive complement activation driven by MBL2 may contribute to synaptic loss in AD
- Genetic associations: Polymorphisms in the MBL2 gene have been linked to altered AD risk in some populations
MBL2 involvement in Parkinson's disease relates to its role in:
- Alpha-synuclein aggregation: MBL2 may interact with alpha-synuclein and influence aggregation kinetics
- Microglial activation: The complement pathway contributes to neuroinflammation in PD
- Gut-brain axis: MBL2 recognizes pathogens in the gut, potentially affecting the gut-brain axis in PD
MBL2 represents a potential therapeutic target for neurodegenerative diseases:
- MBL inhibition: Inhibiting MBL2-mediated complement activation may reduce neuroinflammation
- MBL replacement: In individuals with MBL deficiency, replacement therapy might support immune function
- Modulation strategies: Small molecules that modulate MBL2 function could have neuroprotective effects
Common polymorphisms in the MBL2 gene affect protein levels and function:
- Promoter variants: The -550 G/C (rs11003124), -221 G/C (rs7096206), and +4 C/T (rs7095891) polymorphisms influence MBL2 expression
- Coding variants: Codon 52 (Arg→Cys, rs5030737), codon 54 (Gly→Asp, rs1800450), and codon 57 (Gly→Glu, rs1800451) variants affect oligomerization and function
These polymorphisms determine MBL2 serum concentrations, ranging from deficient (<100 ng/mL) to high (>1000 ng/mL) levels.
MBL2 deficiency affects approximately 5-10% of populations and increases susceptibility to infections. However, the relationship between MBL2 deficiency and neurodegeneration remains complex:
- Some studies suggest MBL2 deficiency may paradoxically reduce neuroinflammation
- Others indicate increased infection-related neuronal damage in deficient individuals